Find clinical trials for Non-Small-Cell Lung Cancer in Madrid, MD

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...

3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...

survival (PFS) for the treatment of first-line stage IV non-small cell lung cancer (NSCLC) patients, lea...

in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...

is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung Cancer (NSCLC). This...

type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...

with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...

This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small...

over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non...